Neueste Storys

Filtern
  • 24.01.2019 – 15:07

    TetraPak

    New Tetra Pak CEO Appointed

    Pully, Switzerland (ots/PRNewswire) - The Tetra Laval Group Board has appointed Mr Adolfo Orive, President & CEO of Tetra Pak effective April 1, 2019. The appointment follows the decision by Mr Dennis Jönsson to step down from his position after 14 years as President & CEO and 36 years with the company. (Logo: https://mma.prnewswire.com/media/813029/Tetra_Laval_Logo.jpg ) (Photo: https://mma.prnewswire.com/media/813041/Tetra_Pak_Adolfo_Orive.jpg ) Adolfo Orive, presently ...

  • 24.01.2019 – 14:01

    Merck Healthcare Germany

    Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors

    Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas - Merck retains the rights to both compounds in all other disease areas, including oncology - Merck retains the rights to utilize and ...

  • 23.01.2019 – 16:02

    Philogen

    Philogen Announces Collaboration With Celgene

    Siena, Italy (ots/PRNewswire) - Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Celgene, to discover and develop a new class of immunomodulatory therapeutics. (Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg ) "We are extremely pleased to establish a new collaboration with Celgene, a leader in the discovery and development ...

  • 23.01.2019 – 16:01

    Philogen

    Philogen Announces Collaboration

    Siena, Italy (ots/PRNewswire) - Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Novartis to discover and develop a new class of immunomodulatory therapeutics. (Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg ) "We are extremely pleased to establish a new collaboration with Novartis, a leader in the discovery and development of therapies for cancer patients," commented Dr. ...